Vestal Point Capital, LP Passage Bio, Inc. Transaction History
Vestal Point Capital, LP
- $1.34 Trillion
- Q2 2024
A detailed history of Vestal Point Capital, LP transactions in Passage Bio, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 6,052,000 shares of PASG stock, worth $3.63 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
6,052,000
Previous 4,500,000
34.49%
Holding current value
$3.63 Million
Previous $6.08 Billion
20.88%
% of portfolio
0.36%
Previous 0.5%
Shares
2 transactions
Others Institutions Holding PASG
# of Institutions
46Shares Held
32.7MCall Options Held
8.3KPut Options Held
400-
Orbimed Advisors LLC San Diego, CA10.1MShares$6.07 Million0.19% of portfolio
-
Versant Venture Management, LLC San Francisco, CA4.03MShares$2.42 Million7.06% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$1.5 Million2.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$1.24 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.5MShares$900,0000.14% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $32.7M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...